Statins should be offered to everyone who has chronic kidney disease, says NICE

NICE

27 July 2017 - Healthcare professionals should offer statins to millions of people with chronic kidney disease. 

This will help to manage their increased risk of cardiovascular disease, says NICE.

The new NICE standard lists atorvastatin as the preferred statin to offer patients because it is both clinically and cost effective.

Read NICE press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Medicine , Market access